Development and clinical application of an immunofluorometric assay for intact parathyroid hormone. 1994

J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
Departamento de Medicina, Escola Paulista de Medicina, SP, Brasil.

Parathyroid hormone (PTH) is a linear peptide of 84 amino acids that is found in serum mainly in the form of carboxyl-terminal fragments. The biological activity of PTH depends on the presence of the amino-terminal portion and in circulation is limited to the intact molecule. We describe an immunofluorometric assay for the measurement of PTH-(1-84) based on a chicken egg yolk-derived amino-terminal antibody bound to microtiter plates by an anti-chicken Ig monoclonal antibody. As tracer antibody we employed a Europium-labelled carboxyl-terminal specific monoclonal antibody produced from a mouse immunized with hPTH-(53-84)-BSA conjugate. The assay included an initial overnight incubation of the sample and the solid phase-bound amino-terminal antibody, followed by washing and addition of the tracer antibody, and an additional two hours of incubation prior to fluorescence reading. The least-detectable dose was in the order of 2.5 pg/ml and preliminary studies in 40 normal adults showed values in the range of 4 to 70 pg/ml; for 12 patients with surgery-proven primary hyperparathyroidism values ranged from 109 to 743 pg/ml and for 34 patients with humoral hypercalcemia of malignancy from 2.5 to 66 pg/ml. We conclude that this assay, with its increased sensitivity and specificity, will be a valuable tool in the study of PTH secretion in normal and pathological situations.

UI MeSH Term Description Entries
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015200 Fluoroimmunoassay The use of fluorescence spectrometry to obtain quantitative results for the FLUORESCENT ANTIBODY TECHNIQUE. One advantage over the other methods (e.g., radioimmunoassay) is its extreme sensitivity, with a detection limit on the order of tenths of microgram/liter. Immunofluorometric Assay,Time-Resolved Immunofluorometric Assay,Assay, Immunofluorometric,Assay, Time-Resolved Immunofluorometric,Assays, Immunofluorometric,Assays, Time-Resolved Immunofluorometric,Fluoroimmunoassays,Immunofluorometric Assay, Time-Resolved,Immunofluorometric Assays,Immunofluorometric Assays, Time-Resolved,Time Resolved Immunofluorometric Assay,Time-Resolved Immunofluorometric Assays

Related Publications

J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
November 1998, Annals of clinical biochemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
November 1997, Annals of clinical biochemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
January 1990, Annals of clinical biochemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
December 1988, Clinica chimica acta; international journal of clinical chemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
January 1983, Metabolic bone disease & related research,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
March 1996, Journal of the Formosan Medical Association = Taiwan yi zhi,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
July 1993, American clinical laboratory,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
November 1988, Annals of clinical biochemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
December 1998, Analytical biochemistry,
J G Vieira, and S K Nishida, and T S Kasamatsu, and E C Amarante, and I S Kunii
April 1986, Clinical endocrinology,
Copied contents to your clipboard!